Cape Investment Advisory’s State Street Real Estate Select Sector SPDR ETF XLRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2K Buy
+481
New +$21.2K 0.01% 689
2026
Q1
Sell
-94
Closed -$3.79K 1238
2025
Q4
$3.79K Sell
94
-104
-53% -$4.28K ﹤0.01% 973
2025
Q3
$8.34K Sell
198
-15
-7% -$627 0.01% 439
2025
Q2
$8.82K Buy
213
+103
+94% +$4.23K ﹤0.01% 652
2025
Q1
$4.6K Hold
110
﹤0.01% 765
2024
Q4
$4.47K Sell
110
-28
-20% -$1.21K ﹤0.01% 765
2024
Q3
$6.16K Hold
138
﹤0.01% 661
2024
Q2
$5.3K Hold
138
﹤0.01% 652
2024
Q1
$5.46K Hold
138
﹤0.01% 634
2023
Q4
$5.53K Hold
138
﹤0.01% 763
2023
Q3
$4.7K Hold
138
﹤0.01% 679
2023
Q2
$5.2K Hold
138
﹤0.01% 649
2023
Q1
$5.16K Buy
+138
New +$5.3K ﹤0.01% 664

Other funds holding XLRE

Cape Investment Advisory's XLRE Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in State Street Real Estate Select Sector SPDR ETF (XLRE) in Q2 2026: 481 shares worth $21.2K. The stake represents 0.01% of the portfolio and ranks #689 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in XLRE as recently as Q4 2025.

Cape Investment Advisory first reported a position in XLRE in Q1 2023 and has held it in 13 quarters since. 798 funds tracked by Wall St. Rank hold XLRE as of Q2 2026.

  • Cape Investment Advisory held 481 shares of State Street Real Estate Select Sector SPDR ETF worth $21.2K as of Q2 2026.
  • State Street Real Estate Select Sector SPDR ETF was a new Cape Investment Advisory position in Q2 2026.
  • State Street Real Estate Select Sector SPDR ETF made up 0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #689 holding.
  • Cape Investment Advisory first reported a position in State Street Real Estate Select Sector SPDR ETF in Q1 2023 and has held it in 13 quarters since.
  • 798 funds tracked by Wall St. Rank held State Street Real Estate Select Sector SPDR ETF as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.